March 2017 FDA Recall Sensodyne by Gsk Consumer Healthcare
D-0624-2017 - Presence of Foreign Substance; low concentration of an additional flavoring ingredient, Patchouli oil resulting in complaints of off flavor/scent

This Class II drug recall was voluntarily initiated by Gsk Consumer Healthcare on March 6, 2017 for the product Sensodyne. The FDA reported the reason for recall as presence of foreign substance; low concentration of an additional flavoring ingredient, patchouli oil resulting in complaints of off flavor/scent. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0624-2017

Reason for Recall
Presence of Foreign Substance; low concentration of an additional flavoring ingredient, Patchouli oil resulting in complaints of off flavor/scent
Initiated
03-06-2017
Reported
04-05-2017
Quantity
56,840 cases

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
GSK Consumer Healthcare
Sensodyne Repair & Protect Whitening, (stannous fluoride 0.45% (0.15% w/v fluoride ion)), Net Wt. 3.4 oz, Distributed by Glaxo SmithKline Consumer Healthcare LP Moon Township PA 15108 --- NDC 0135-0575-01, UPC UPC: 3 10158 84060 2

Batch or Lot Expiration Information

Lot# A6J231, expiration 08/2018; A6J261, expiration 08/2018; A6K171, expiration 08/2018; A6K241, expiration, 09/2018; A6M231, expiration 10/2018